Skip to main content

Table 2 Clinical and laboratory characteristics by tertile distribution of serum IL-38 level

From: Serum interleukin-38 levels correlated with insulin resistance, liver injury and lipids in non-alcoholic fatty liver disease

Indexes

T1

T2

T3

Statistical value, p

p1,p2,p3

Age

32.00(24.00,41.25)

35.50(30.00,42.00)

32.50(25.75,39.00)

4.424,0.110

0.176,1.000,0.250

ALT

16.35(10.58,21.33)

19.80(13.93,31.28)

31.00(19.15,51.48)

30.437,< 0.0001

0.027,< 0.0001,0.010

AST

20.60(18.28,24.20)

23.95(18.68,30.98)

30.85(23.63,41.83)

27.725,< 0.0001

0.114,< 0.0001,0.004

PLT

233.50(194.5286.75)

236.00(204.25,272.75)

220.50(181.00,255.00)

6.337,0.042

1.000,0.080,0.095

NFS

−3.40(−4.02,-2.65)

− 3.01(− 3.72,-2.50)

−2.86(− 3.51,-2.28)

7.982,0.018

0.272,0.015,0.756

FBG

4.65(4.44,4.89)

4.81(4.61,5.32)

4.92(4.64,5.48)

13.605,0.001

0.010,0.002,1.000

HOMA-IR

1.40(1.07,1.65)

1.88(1.43,2.50)

2.78(1.92,4.14)

50.878,< 0.0001

0.001,< 0.0001,0.002

QUICK

0.67(0.64,0.72)

0.615(0.57,0.66)

0.56(0.51,0.61)

50.878,< 0.0001

0.001,< 0.0001,0.002

CRP

0.16(0.13,0.23)

0.22(0.16,0.38)

0.23(0.15,0.35)

10.633,0.005

0.010,0.020,1.000

INS (mU/L)

6.68(5.36,7.68)

8.47(6.68,10.97)

12.69(9.21,15.63)

46.278,< 0.0001

0.004,< 0.0001,0.001

CpS

1.74(1.49,2.05)

2.22(1.83,2.75)

2.705(2.43,3.46)

46.060,< 0.0001

0.001,< 0.0001,0.003

HbA1c

5.30(5.18,5.53)

5.45(5.23,5.80)

5.60(5.30,5.90)

12.448,0.002

0.064,0.002,0.694

WBC

5.37(4.565,5.91)

6.33(5.10,7.58)

6.11(5.50,7.42)

20.186,< 0.0001

0.001,< 0.0001,1.000

NEU

2.93(2.34,3.56)

3.59(2.79,4.74)

3.44(2.78,4.30)

15.887,< 0.0001

0.001,0.006,1.000

ALB

49.55(47.68,51.23)

48.85(47.50,50.28)

49.00(47.83,51.15)

2.258,0.323

0.432,1.000,0.918

PA

247.50(222.50,271.50)

259.50(229.00,286.00)

285.00(267.00,317.00)

22.438,< 0.0001

0.552,< 0.0001,0.003

Urea

4.57(4.17,5.55)

4.41(3.79,5.25)

4.77(3.86,5.52)

1.825,0.401

0.668,1.000,0.806

CREA

59.00(52.75,70.25)

63.50(52.25,74.00)

71.50(62.50,78.00)

13.852,0.001

0.924,0.001,0.027

TRIG

0.99(0.73,1.20)

1.42(0.90,2.23)

1.96(1.41,2.98)

53.150,< 0.0001

< 0.0001,< 0.0001,0.005

CHOL

4.69(4.13,5.19)

4.67(4.11,5.44)

4.99(4.67,5.63)

7.556,0.023

1.000,0.028,0.112

HDL-C

1.54(1.36,1.76)

1.37(1.14,1.62)

1.27(1.07,1.46)

27.448,< 0.0001

0.002,< 0.0001,0.219

LDL-C

2.66(2.31,2.90)

2.63(2.25,3.33)

2.89(2.48,3.19)

5.880,0.053

1.000,0.053,0.306

BMI

21.78(19.91,24.02)

24.23 (21.32,26.26)

25.01 (23.65,27.32)

30.499,< 0.0001

0.002,< 0.0001,0.091

IL-6

1.60(0.98,2.48)

1.98(1.13,2.79)

2.43(1.55,3.40)

12.447,0.002

0.504,0.001,0.095

25(OH)D

19.80(17.20,22.65)

18.85(15.80,22.25)

15.75(12.43,19.83)

18.564,< 0.0001

0.769,< 0.0001,0.007

NF (%)

13.33

48.39

88.33

67.600,0000

< 0.0001,< 0.0001,< 0.0001

  1. p1, T1 vs T2; p2, T1 vs T3; p3, T2 vs T3. BMI Body mass index, ALT Alanine aminotransferase, AST Aspartate aminotransferase, FBG Fasting blood glucose, INS Insulin, CpS C-peptide, HbA1c Hemoglobin A1c, HOMA-IR Homoeostasis model assessment of IR, QUICK Quantitative insulin sensitivity check index, WBC White blood cell, NEU Neutrophil, PLT Platelet, ALB Albumin, PA Prealbumin, CREA Creatinine, TRIG Triglycerides, CHOL Total cholesterol, HDL-C High density liptein cholesterol, LDL-C Low-density lipoprotein cholesterol, IL-6 Interleukin-6, 25(OH) D 25 hydroxy-vitamin D, CRP C-reactive protein, NFS Non-alcoholic fatty liver disease fibrosis score. Measurement data were expressed as median (interquartile range)